Preclinical review of cerivastatin sodium--a step forward in HMG-CoA reductase inhibition.
Atherosclerosis. 1998 Sep;139 Suppl 1:S7-13. doi: 10.1016/s0021-9150(98)00188-9.
Atherosclerosis. 1998.
PMID: 9811153
Review.